Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jen Jen Yeh

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Nature Genetics|September 8, 2015
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinomaRichard A Moffitt, Raoud Marayati, Elizabeth L Flate, et al.
Plos Medicine|July 21, 2010
A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinomaJeran K Stratford, David J Bentrem, Judy M Anderson, et al.
Hepatology Communications|August 5, 2024
Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapyPaul R Burchard, Luis I Ruffolo, Nicholas A Ullman, et al.
Cancer Cell|January 4, 2016
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth SuppressionTikvah K Hayes, Nicole F Neel, Chaoxin Hu, et al.
Cancer Discovery|December 5, 2024
Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic ApproachesYi Xu, Xianlu L Peng, Michael P East, et al.
NPJ Precision Oncology|April 17, 2018
Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion moleculeMałgorzata A Witek, Rachel D Aufforth, Hong Wang, et al.
The Journal of Clinical Investigation|August 5, 2020
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrixHonglin Jiang, Robert J Torphy, Katja Steiger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2020
Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancerDivya Thomas, Satish Sagar, Xiang Liu, et al.
Nature Communications|November 2, 2021
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitorsTeklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, et al.
Nature Communications|June 9, 2017
MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinomaSean T Bailey, Aleisha M Smith, Jordan Kardos, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Nature Genetics|September 8, 2015
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinomaRichard A Moffitt, Raoud Marayati, Elizabeth L Flate, et al.
Plos Medicine|July 21, 2010
A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinomaJeran K Stratford, David J Bentrem, Judy M Anderson, et al.
Hepatology Communications|August 5, 2024
Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapyPaul R Burchard, Luis I Ruffolo, Nicholas A Ullman, et al.
Cancer Cell|January 4, 2016
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth SuppressionTikvah K Hayes, Nicole F Neel, Chaoxin Hu, et al.
Cancer Discovery|December 5, 2024
Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic ApproachesYi Xu, Xianlu L Peng, Michael P East, et al.
NPJ Precision Oncology|April 17, 2018
Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion moleculeMałgorzata A Witek, Rachel D Aufforth, Hong Wang, et al.
The Journal of Clinical Investigation|August 5, 2020
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrixHonglin Jiang, Robert J Torphy, Katja Steiger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 28, 2020
Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancerDivya Thomas, Satish Sagar, Xiang Liu, et al.
Nature Communications|November 2, 2021
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitorsTeklab Gebregiworgis, Yoshihito Kano, Jonathan St-Germain, et al.
Nature Communications|June 9, 2017
MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinomaSean T Bailey, Aleisha M Smith, Jordan Kardos, et al.
Pageof 12